LENSAR Inc Overview
Industry: Medical Devices
Sector: Healthcare
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida. LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary Read MoreReported Results
What the company reported, with filing details kept small.
Quarterly result summary
Revenue was $13.7M (reported). Operating income was $2.1M (-134% YoY). Net income was $3.5M (-300% YoY).
Revenue
$13.7M
reported
Operating income
$2.1M
-134% YoY
Net income
$3.5M
-300% YoY
Adjusted EBITDA
$3.6
reported
What changed
- Revenue reported to $13.7M.
- Operating income -134% YoY to $2.1M.
- Net income -300% YoY to $3.5M.
Guidance / outlook
No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.
Earnings release
Open filing
Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.
Other recent earnings materials
SEC filing
10-Q
Aug 13, 2026
SEC filing
8-K
Aug 13, 2026
SEC filing
10-Q
May 08, 2026
SEC filing
8-K
May 08, 2026
Earnings release
Earnings release
May 08, 2026
SEC filing
10-K/A
Apr 30, 2026
SEC filing
10-K
Mar 31, 2026
SEC filing
8-K
Mar 31, 2026
Earnings release
Earnings release
Mar 31, 2026
SEC filing
10-Q
Nov 06, 2025
SEC filing
8-K
Nov 06, 2025
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
LENSAR, Inc. Q2 2026 Earnings Call Summary
Headline from Yahoo Finance: LENSAR, Inc. Q2 2026 Earnings Call Summary.
Earnings call transcript: LENSAR beats on Q2 2026 profit, shares jump premarket
Headline from Investing.com: Earnings call transcript: LENSAR beats on Q2 2026 profit, shares jump premarket.
LENSAR earnings beat by $0.31, revenue topped estimates
Headline from Investing.com: LENSAR earnings beat by $0.31, revenue topped estimates.
Earnings To Watch: LENSAR Inc (LNSR) Q2 2026 -- GF Value Sees 13% Upside
Headline from Yahoo Finance: Earnings To Watch: LENSAR Inc (LNSR) Q2 2026 -- GF Value Sees 13% Upside.
Why is LENSAR stock surging today?
Headline from Investing.com: Why is LENSAR stock surging today?
LENSAR® Reports Second Quarter 2026 Results and Provides Business Update
Headline from Yahoo Finance: LENSAR® Reports Second Quarter 2026 Results and Provides Business Update.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
Verified SEC statements load when this section enters view.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.